Patients with NPC exhibiting a high infiltrating density of CD20+ B cells showed significantly better 5-year DMFS, OS, and PFS compared to those of patients with a low infiltrating density. The gene discussed is MS4A1; the disease is nasopharyngeal carcinoma.